Impact of COVID-19 Outbreak on Nicardipine Hydrochloride Injection, Global Market Research Report 2020

Publisher Name :
Date: 22-May-2020
No. of pages: 121
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Nicardipine Hydrochloride Injection market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyzes the impact of Coronavirus COVID-19 on the Nicardipine Hydrochloride Injection industry.

Segment by Type, the Nicardipine Hydrochloride Injection market is segmented into

  • 20 mg / 200 mL

  • 40 mg / 200 mL

Segment by Application

  • Hospital

  • Clinic

  • Recovery Center

Global Nicardipine Hydrochloride Injection Market: Regional Analysis

The Nicardipine Hydrochloride Injection market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Nicardipine Hydrochloride Injection market report are:

  • North America

  • U.S.

  • Canada

  • Europe

  • Germany

  • France

  • U.K.

  • Italy

  • Russia

  • Asia-Pacific

  • China

  • Japan

  • South Korea

  • India

  • Australia

  • Taiwan

  • Indonesia

  • Thailand

  • Malaysia

  • Philippines

  • Vietnam

  • Latin America

  • Mexico

  • Brazil

  • Argentina

  • Middle East & Africa

  • Turkey

  • Saudi Arabia

  • UAE

Global Nicardipine Hydrochloride Injection Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Nicardipine Hydrochloride Injection market include:

  • Baxter

  • Hikma

  • Mylan

  • Sun Pharma

  • Chiesi

  • Wockhardt

  • DMS Pharmaceutical

  • Sandoz

  • Navinta

  • Teva

  • Shanghai Furen Medicine

Impact of COVID-19 Outbreak on Nicardipine Hydrochloride Injection, Global Market Research Report 2020

Table of Contents
1 Nicardipine Hydrochloride Injection Market Overview
1.1 Product Overview and Scope of Nicardipine Hydrochloride Injection
1.2 Covid-19 Impact on Nicardipine Hydrochloride Injection Segment by Type
1.2.1 Global Nicardipine Hydrochloride Injection Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 20 mg / 200 mL
1.2.3 40 mg / 200 mL
1.3 Covid-19 Impact on Nicardipine Hydrochloride Injection Segment by Application
1.3.1 Nicardipine Hydrochloride Injection Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Recovery Center
1.4 Covid-19 Impact on Global Nicardipine Hydrochloride Injection Market Size Estimates and Forecasts
1.4.1 Global Nicardipine Hydrochloride Injection Revenue 2015-2026
1.4.2 Global Nicardipine Hydrochloride Injection Sales 2015-2026
1.4.3 Nicardipine Hydrochloride Injection Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Nicardipine Hydrochloride Injection Industry
1.7 COVID-19 Impact: Nicardipine Hydrochloride Injection Market Trends
2 Covid-19 Impact on Global Nicardipine Hydrochloride Injection Market Competition by Manufacturers
2.1 Global Nicardipine Hydrochloride Injection Sales Market Share by Manufacturers (2015-2020)
2.2 Global Nicardipine Hydrochloride Injection Revenue Share by Manufacturers (2015-2020)
2.3 Global Nicardipine Hydrochloride Injection Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Nicardipine Hydrochloride Injection Manufacturing Sites, Area Served, Product Type
2.5 Nicardipine Hydrochloride Injection Market Competitive Situation and Trends
2.5.1 Nicardipine Hydrochloride Injection Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Nicardipine Hydrochloride Injection Players (Opinion Leaders)
3 Covid-19 Impact on Nicardipine Hydrochloride Injection Retrospective Market Scenario by Region
3.1 Global Nicardipine Hydrochloride Injection Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Nicardipine Hydrochloride Injection Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Nicardipine Hydrochloride Injection Market Facts & Figures by Country
3.3.1 North America Nicardipine Hydrochloride Injection Sales by Country
3.3.2 North America Nicardipine Hydrochloride Injection Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Nicardipine Hydrochloride Injection Market Facts & Figures by Country
3.4.1 Europe Nicardipine Hydrochloride Injection Sales by Country
3.4.2 Europe Nicardipine Hydrochloride Injection Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Nicardipine Hydrochloride Injection Market Facts & Figures by Region
3.5.1 Asia Pacific Nicardipine Hydrochloride Injection Sales by Region
3.5.2 Asia Pacific Nicardipine Hydrochloride Injection Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Nicardipine Hydrochloride Injection Market Facts & Figures by Country
3.6.1 Latin America Nicardipine Hydrochloride Injection Sales by Country
3.6.2 Latin America Nicardipine Hydrochloride Injection Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Nicardipine Hydrochloride Injection Market Facts & Figures by Country
3.7.1 Middle East and Africa Nicardipine Hydrochloride Injection Sales by Country
3.7.2 Middle East and Africa Nicardipine Hydrochloride Injection Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Covid-19 Impact on Global Nicardipine Hydrochloride Injection Historic Market Analysis by Type
4.1 Global Nicardipine Hydrochloride Injection Sales Market Share by Type (2015-2020)
4.2 Global Nicardipine Hydrochloride Injection Revenue Market Share by Type (2015-2020)
4.3 Global Nicardipine Hydrochloride Injection Price Market Share by Type (2015-2020)
4.4 Global Nicardipine Hydrochloride Injection Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Covid-19 Impact on Global Nicardipine Hydrochloride Injection Historic Market Analysis by Application
5.1 Global Nicardipine Hydrochloride Injection Sales Market Share by Application (2015-2020)
5.2 Global Nicardipine Hydrochloride Injection Revenue Market Share by Application (2015-2020)
5.3 Global Nicardipine Hydrochloride Injection Price by Application (2015-2020)
6 Company Profiles and Key Figures in Nicardipine Hydrochloride Injection Business
6.1 Baxter
6.1.1 Corporation Information
6.1.2 Baxter Description, Business Overview and Total Revenue
6.1.3 Baxter Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Baxter Products Offered
6.1.5 Baxter Recent Development and Response to COVID-19
6.2 Hikma
6.2.1 Hikma Corporation Information
6.2.2 Hikma Description, Business Overview and Total Revenue
6.2.3 Hikma Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Hikma Products Offered
6.2.5 Hikma Recent Development and Response to COVID-19
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description, Business Overview and Total Revenue
6.3.3 Mylan Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Mylan Products Offered
6.3.5 Mylan Recent Development and Response to COVID-19
6.4 Sun Pharma
6.4.1 Sun Pharma Corporation Information
6.4.2 Sun Pharma Description, Business Overview and Total Revenue
6.4.3 Sun Pharma Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Sun Pharma Products Offered
6.4.5 Sun Pharma Recent Development and Response to COVID-19
6.5 Chiesi
6.5.1 Chiesi Corporation Information
6.5.2 Chiesi Description, Business Overview and Total Revenue
6.5.3 Chiesi Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Chiesi Products Offered
6.5.5 Chiesi Recent Development and Response to COVID-19
6.6 Wockhardt
6.6.1 Wockhardt Corporation Information
6.6.2 Wockhardt Description, Business Overview and Total Revenue
6.6.3 Wockhardt Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Wockhardt Products Offered
6.6.5 Wockhardt Recent Development and Response to COVID-19
6.7 DMS Pharmaceutical
6.6.1 DMS Pharmaceutical Corporation Information
6.6.2 DMS Pharmaceutical Description, Business Overview and Total Revenue
6.6.3 DMS Pharmaceutical Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2015-2020)
6.4.4 DMS Pharmaceutical Products Offered
6.7.5 DMS Pharmaceutical Recent Development and Response to COVID-19
6.8 Sandoz
6.8.1 Sandoz Corporation Information
6.8.2 Sandoz Description, Business Overview and Total Revenue
6.8.3 Sandoz Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Sandoz Products Offered
6.8.5 Sandoz Recent Development and Response to COVID-19
6.9 Navinta
6.9.1 Navinta Corporation Information
6.9.2 Navinta Description, Business Overview and Total Revenue
6.9.3 Navinta Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Navinta Products Offered
6.9.5 Navinta Recent Development and Response to COVID-19
6.10 Teva
6.10.1 Teva Corporation Information
6.10.2 Teva Description, Business Overview and Total Revenue
6.10.3 Teva Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Teva Products Offered
6.10.5 Teva Recent Development and Response to COVID-19
6.11 Shanghai Furen Medicine
6.11.1 Shanghai Furen Medicine Corporation Information
6.11.2 Shanghai Furen Medicine Nicardipine Hydrochloride Injection Description, Business Overview and Total Revenue
6.11.3 Shanghai Furen Medicine Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Shanghai Furen Medicine Products Offered
6.11.5 Shanghai Furen Medicine Recent Development and Response to COVID-19
7 Nicardipine Hydrochloride Injection Manufacturing Cost Analysis
7.1 Nicardipine Hydrochloride Injection Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Nicardipine Hydrochloride Injection
7.4 Nicardipine Hydrochloride Injection Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Nicardipine Hydrochloride Injection Distributors List
8.3 Nicardipine Hydrochloride Injection Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Nicardipine Hydrochloride Injection Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Nicardipine Hydrochloride Injection by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Nicardipine Hydrochloride Injection by Type (2021-2026)
10.2 Nicardipine Hydrochloride Injection Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Nicardipine Hydrochloride Injection by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Nicardipine Hydrochloride Injection by Application (2021-2026)
10.3 Nicardipine Hydrochloride Injection Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Nicardipine Hydrochloride Injection by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Nicardipine Hydrochloride Injection by Region (2021-2026)
10.4 North America Nicardipine Hydrochloride Injection Estimates and Projections (2021-2026)
10.5 Europe Nicardipine Hydrochloride Injection Estimates and Projections (2021-2026)
10.6 Asia Pacific Nicardipine Hydrochloride Injection Estimates and Projections (2021-2026)
10.7 Latin America Nicardipine Hydrochloride Injection Estimates and Projections (2021-2026)
10.8 Middle East and Africa Nicardipine Hydrochloride Injection Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables

Table 1. Global Nicardipine Hydrochloride Injection Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Nicardipine Hydrochloride Injection Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Nicardipine Hydrochloride Injection Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Nicardipine Hydrochloride Injection Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Nicardipine Hydrochloride Injection Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Nicardipine Hydrochloride Injection Players to Combat Covid-19 Impact
Table 9. Global Key Nicardipine Hydrochloride Injection Manufacturers Covered in This Study
Table 10. Global Nicardipine Hydrochloride Injection Sales (K Units) by Manufacturers (2015-2020)
Table 11. Global Nicardipine Hydrochloride Injection Sales Share by Manufacturers (2015-2020)
Table 12. Global Nicardipine Hydrochloride Injection Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Nicardipine Hydrochloride Injection Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Nicardipine Hydrochloride Injection Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Nicardipine Hydrochloride Injection Sales Sites and Area Served
Table 16. Manufacturers Nicardipine Hydrochloride Injection Product Types
Table 17. Global Nicardipine Hydrochloride Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Nicardipine Hydrochloride Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nicardipine Hydrochloride Injection as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Nicardipine Hydrochloride Injection Players
Table 21. Global Nicardipine Hydrochloride Injection Sales (K Units) by Region (2015-2020)
Table 22. Global Nicardipine Hydrochloride Injection Sales Market Share by Region (2015-2020)
Table 23. Global Nicardipine Hydrochloride Injection Revenue (Million US$) by Region (2015-2020)
Table 24. Global Nicardipine Hydrochloride Injection Revenue Market Share by Region (2015-2020)
Table 25. North America Nicardipine Hydrochloride Injection Sales by Country (2015-2020) (K Units)
Table 26. North America Nicardipine Hydrochloride Injection Sales Market Share by Country (2015-2020)
Table 27. North America Nicardipine Hydrochloride Injection Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Nicardipine Hydrochloride Injection Revenue Market Share by Country (2015-2020)
Table 29. Europe Nicardipine Hydrochloride Injection Sales by Country (2015-2020) (K Units)
Table 30. Europe Nicardipine Hydrochloride Injection Sales Market Share by Country (2015-2020)
Table 31. Europe Nicardipine Hydrochloride Injection Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Nicardipine Hydrochloride Injection Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Nicardipine Hydrochloride Injection Sales by Region (2015-2020) (K Units)
Table 34. Asia Pacific Nicardipine Hydrochloride Injection Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Nicardipine Hydrochloride Injection Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Nicardipine Hydrochloride Injection Revenue Market Share by Region (2015-2020)
Table 37. Latin America Nicardipine Hydrochloride Injection Sales by Country (2015-2020) (K Units)
Table 38. Latin America Nicardipine Hydrochloride Injection Sales Market Share by Country (2015-2020)
Table 39. Latin America Nicardipine Hydrochloride Injection Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Nicardipine Hydrochloride Injection Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Nicardipine Hydrochloride Injection Sales by Country (2015-2020) (K Units)
Table 42. Middle East and Africa Nicardipine Hydrochloride Injection Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Nicardipine Hydrochloride Injection Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Nicardipine Hydrochloride Injection Revenue Market Share by Country (2015-2020)
Table 45. Global Nicardipine Hydrochloride Injection Sales (K Units) by Type (2015-2020)
Table 46. Global Nicardipine Hydrochloride Injection Sales Share by Type (2015-2020)
Table 47. Global Nicardipine Hydrochloride Injection Revenue (Million US$) by Type (2015-2020)
Table 48. Global Nicardipine Hydrochloride Injection Revenue Share by Type (2015-2020)
Table 49. Global Nicardipine Hydrochloride Injection Price (US$/Unit) by Type (2015-2020)
Table 50. Global Nicardipine Hydrochloride Injection Sales (K Units) by Application (2015-2020)
Table 51. Global Nicardipine Hydrochloride Injection Sales Market Share by Application (2015-2020)
Table 52. Global Nicardipine Hydrochloride Injection Sales Growth Rate by Application (2015-2020)
Table 53. Baxter Nicardipine Hydrochloride Injection Corporation Information
Table 54. Baxter Description and Business Overview
Table 55. Baxter Nicardipine Hydrochloride Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Baxter Main Product
Table 57. Baxter Recent Development
Table 58. Hikma Nicardipine Hydrochloride Injection Corporation Information
Table 59. Hikma Corporation Information
Table 60. Hikma Nicardipine Hydrochloride Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Hikma Main Product
Table 62. Hikma Recent Development
Table 63. Mylan Nicardipine Hydrochloride Injection Corporation Information
Table 64. Mylan Corporation Information
Table 65. Mylan Nicardipine Hydrochloride Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Mylan Main Product
Table 67. Mylan Recent Development
Table 68. Sun Pharma Nicardipine Hydrochloride Injection Corporation Information
Table 69. Sun Pharma Corporation Information
Table 70. Sun Pharma Nicardipine Hydrochloride Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Sun Pharma Main Product
Table 72. Sun Pharma Recent Development
Table 73. Chiesi Nicardipine Hydrochloride Injection Corporation Information
Table 74. Chiesi Corporation Information
Table 75. Chiesi Nicardipine Hydrochloride Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Chiesi Main Product
Table 77. Chiesi Recent Development
Table 78. Wockhardt Nicardipine Hydrochloride Injection Corporation Information
Table 79. Wockhardt Corporation Information
Table 80. Wockhardt Nicardipine Hydrochloride Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Wockhardt Main Product
Table 82. Wockhardt Recent Development
Table 83. DMS Pharmaceutical Nicardipine Hydrochloride Injection Corporation Information
Table 84. DMS Pharmaceutical Corporation Information
Table 85. DMS Pharmaceutical Nicardipine Hydrochloride Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. DMS Pharmaceutical Main Product
Table 87. DMS Pharmaceutical Recent Development
Table 88. Sandoz Nicardipine Hydrochloride Injection Corporation Information
Table 89. Sandoz Corporation Information
Table 90. Sandoz Nicardipine Hydrochloride Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Sandoz Main Product
Table 92. Sandoz Recent Development
Table 93. Navinta Nicardipine Hydrochloride Injection Corporation Information
Table 94. Navinta Corporation Information
Table 95. Navinta Nicardipine Hydrochloride Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 96. Navinta Main Product
Table 97. Navinta Recent Development
Table 98. Teva Nicardipine Hydrochloride Injection Corporation Information
Table 99. Teva Corporation Information
Table 100. Teva Nicardipine Hydrochloride Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 101. Teva Main Product
Table 102. Teva Recent Development
Table 103. Shanghai Furen Medicine Nicardipine Hydrochloride Injection Corporation Information
Table 104. Shanghai Furen Medicine Corporation Information
Table 105. Shanghai Furen Medicine Nicardipine Hydrochloride Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 106. Shanghai Furen Medicine Main Product
Table 107. Shanghai Furen Medicine Recent Development
Table 108. Sales Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Nicardipine Hydrochloride Injection Distributors List
Table 111. Nicardipine Hydrochloride Injection Customers List
Table 112. Market Key Trends
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Global Nicardipine Hydrochloride Injection Sales (K Units) Forecast by Type (2021-2026)
Table 116. Global Nicardipine Hydrochloride Injection Sales Market Share Forecast by Type (2021-2026)
Table 117. Global Nicardipine Hydrochloride Injection Revenue (Million US$) Forecast by Type (2021-2026)
Table 118. Global Nicardipine Hydrochloride Injection Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 119. Global Nicardipine Hydrochloride Injection Sales (K Units) Forecast by Application (2021-2026)
Table 120. Global Nicardipine Hydrochloride Injection Revenue (Million US$) Forecast by Application (2021-2026)
Table 121. Global Nicardipine Hydrochloride Injection Sales (K Units) Forecast by Region (2021-2026)
Table 122. Global Nicardipine Hydrochloride Injection Sales Market Share Forecast by Region (2021-2026)
Table 123. Global Nicardipine Hydrochloride Injection Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Global Nicardipine Hydrochloride Injection Revenue Market Share Forecast by Region (2021-2026)
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures

Figure 1. Picture of Nicardipine Hydrochloride Injection
Figure 2. Global Nicardipine Hydrochloride Injection Sales Market Share by Type: 2020 VS 2026
Figure 3. 20 mg / 200 mL Product Picture
Figure 4. 40 mg / 200 mL Product Picture
Figure 5. Global Nicardipine Hydrochloride Injection Consumption Market Share by Application: 2020 VS 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Recovery Center
Figure 9. Global Nicardipine Hydrochloride Injection Market Size 2015-2026 (US$ Million)
Figure 10. Global Nicardipine Hydrochloride Injection Sales Capacity (K Units) (2015-2026)
Figure 11. Global Nicardipine Hydrochloride Injection Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Nicardipine Hydrochloride Injection Sales Share by Manufacturers in 2020
Figure 13. Global Nicardipine Hydrochloride Injection Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Nicardipine Hydrochloride Injection Revenue in 2019
Figure 15. Nicardipine Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Nicardipine Hydrochloride Injection Sales Market Share by Region (2015-2020)
Figure 17. Global Nicardipine Hydrochloride Injection Sales Market Share by Region in 2019
Figure 18. Global Nicardipine Hydrochloride Injection Revenue Market Share by Region (2015-2020)
Figure 19. Global Nicardipine Hydrochloride Injection Revenue Market Share by Region in 2019
Figure 20. North America Nicardipine Hydrochloride Injection Sales Market Share by Country in 2019
Figure 21. North America Nicardipine Hydrochloride Injection Revenue Market Share by Country in 2019
Figure 22. U.S. Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 23. U.S. Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 25. Canada Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Nicardipine Hydrochloride Injection Sales Market Share by Country in 2019
Figure 27. Europe Nicardipine Hydrochloride Injection Revenue Market Share by Country in 2019
Figure 28. Germany Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 29. Germany Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 31. France Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 35. Italy Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 37. Russia Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Nicardipine Hydrochloride Injection Sales Market Share by Region in 2019
Figure 39. Asia Pacific Nicardipine Hydrochloride Injection Revenue Market Share by Region in 2019
Figure 40. China Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 41. China Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 43. Japan Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 47. India Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 49. Australia Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 53. Indonesia Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 55. Thailand Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 57. Malaysia Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 59. Philippines Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 61. Vietnam Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Nicardipine Hydrochloride Injection Sales Market Share by Country in 2019
Figure 63. Latin America Nicardipine Hydrochloride Injection Revenue Market Share by Country in 2019
Figure 64. Mexico Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 65. Mexico Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 67. Brazil Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 69. Argentina Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Nicardipine Hydrochloride Injection Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Nicardipine Hydrochloride Injection Revenue Market Share by Country in 2019
Figure 72. Turkey Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 73. Turkey Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 75. Saudi Arabia Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. UAE Nicardipine Hydrochloride Injection Sales Growth Rate (2015-2020) (K Units)
Figure 77. UAE Nicardipine Hydrochloride Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Nicardipine Hydrochloride Injection by Type (2015-2020)
Figure 79. Sales Market Share of Nicardipine Hydrochloride Injection by Type in 2019
Figure 80. Revenue Share of Nicardipine Hydrochloride Injection by Type (2015-2020)
Figure 81. Revenue Market Share of Nicardipine Hydrochloride Injection by Type in 2019
Figure 82. Global Nicardipine Hydrochloride Injection Sales Growth by Type (2015-2020) (K Units)
Figure 83. Global Nicardipine Hydrochloride Injection Sales Market Share by Application (2015-2020)
Figure 84. Global Nicardipine Hydrochloride Injection Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Nicardipine Hydrochloride Injection by Application (2015-2020)
Figure 86. Global Revenue Share of Nicardipine Hydrochloride Injection by Application in 2020
Figure 87. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Hikma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Sun Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Chiesi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Wockhardt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. DMS Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Sandoz Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Navinta Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Shanghai Furen Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Price Trend of Key Raw Materials
Figure 99. Manufacturing Cost Structure of Nicardipine Hydrochloride Injection
Figure 100. Manufacturing Process Analysis of Nicardipine Hydrochloride Injection
Figure 101. Nicardipine Hydrochloride Injection Industrial Chain Analysis
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. North America Nicardipine Hydrochloride Injection Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 106. North America Nicardipine Hydrochloride Injection Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Nicardipine Hydrochloride Injection Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Nicardipine Hydrochloride Injection Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Nicardipine Hydrochloride Injection Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Nicardipine Hydrochloride Injection Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Nicardipine Hydrochloride Injection Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Nicardipine Hydrochloride Injection Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Nicardipine Hydrochloride Injection Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Nicardipine Hydrochloride Injection Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs